Cleveland Clinic and IBM researchers are using quantum computing to tackle one of the most challenging problems in immuno-oncology: predicting which tumor mutations will trigger an immune response.
A study explores how AI and ML can improve early detection of neurological diseases, including Parkinson’s disease, ...